Davis-based AgraQuest Inc. and Bayer CropScience have expanded their previous home and garden fungicide supply agreement beyond the U.S. to three European countries.
Under the terms of this second agreement, AgraQuest technology based on its proprietary strain of Bacillus subtilis (QST 713) will be used for Bayer’s Natria home and garden market in France and Italy starting in 2013 and Germany in 2014. Financial terms of the agreement were not disclosed.
AgraQuest’s naturally derived Bacillus subtilis QST 713 is the same active ingredient that has been commercialized by Bayer Advanced in the U.S. for home and garden customers since 2009. The active ingredient also has been used by commercial farmers and growers for nearly a decade to treat fruits and vegetables for common bacterial and fungal diseases.
“We are very excited about expanding our collaboration with Bayer, carrying our shared success from the U.S. market to the key home and garden markets in Europe,” Mike Miille, president and COO for AgraQuest and head of AgraQuest’s bioInnovations division, said in a news release. “Bayer is an excellent partner for expanding this plank of AgraQuest’s home and garden strategy.”
AgraQuest is a biotechnology company that focuses on discovering, manufacturing and marketing highly effective pest management products for agricultural, institutional and home markets while reducing the chemical load on the environment and creating sustainable agriculture opportunities. For more information, visit http://www.agraquest.com.
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, based in Monheim, Germany, is a subsidiary of Bayer AG that focuses on crop protection, non-agricultural pest control, seeds and traits. Bayer CropScience has a global workforce of 18,700 and is represented in more than 120 countries. For more information, visit http://www.bayercropscience.com.